APA

Askari N., Moin M., Sanati M., Tajdini M., Hosseini S., Modabbernia A., Najand B., Salimi S., Tabrizi M., Ashrafi M., Hajiaghaee R. & Akhondzadeh S. (20130214). Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. : CNS drugs.

Chicago

Askari Neda, Moin Mahdieh, Sanati Mohammad, Tajdini Masih, Hosseini Seyed-Mohammad-Reza, Modabbernia Amirhossein, Najand Babak, Salimi Samrand, Tabrizi Mina, Ashrafi Mandana, Hajiaghaee Reza and Akhondzadeh Shahin. 20130214. Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. : CNS drugs.

Harvard

Askari N., Moin M., Sanati M., Tajdini M., Hosseini S., Modabbernia A., Najand B., Salimi S., Tabrizi M., Ashrafi M., Hajiaghaee R. and Akhondzadeh S. (20130214). Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. : CNS drugs.

MLA

Askari Neda, Moin Mahdieh, Sanati Mohammad, Tajdini Masih, Hosseini Seyed-Mohammad-Reza, Modabbernia Amirhossein, Najand Babak, Salimi Samrand, Tabrizi Mina, Ashrafi Mandana, Hajiaghaee Reza and Akhondzadeh Shahin. Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. : CNS drugs. 20130214.